HELP     Sign In

15q21.3-q22.2CNV Type: Deletion


Largest CNV size: 8700000 bp

Statistics Box:
Number of Reports: 6



Summary Information

Summary statement in development

Additional Locus Information

Genome browsers

USCS Symbol             NCBI Symbol

Decipher

            Decipher Symbol

References

Major Reports

Title
Author, Year
Report Class
CNV Type
An evidence-based approach to establish the functional and clinical significance of copy number variants in intellectual and developmental disabili...
Deletion
Overlapping microdeletions involving 15q22.2 narrow the critical region for intellectual disability to NARG2 and RORA.
Deletion

Minor Reports

Title
Author, Year
Report Class
CNV Type
The clinical utility of molecular karyotyping using high-resolution array-comparative genomic hybridization.
Deletion
Recurrent copy number variations as risk factors for Autism Spectrum Disorders: analysis of the clinical implications.
Deletion
Rare Inherited and De Novo CNVs Reveal Complex Contributions to ASD Risk in Multiplex Families.
Duplication
NA
Deletion

Cases

Cohort ID
Author, Year
Descripton
Cohort Size
Diagnosis
Age
Gender
CNV Size
Deletion
Duplication
Total CNV's
 kaminsky_11_DD/ID/ASD_discovery_cases
 Cases from the International Standards for Cytogenomic Arrays (ISCA) consortium
 15749
 Unexplained developmental delay, intellectual disability, dysmorphic features, multiple congenital anomalies, autism spectrum disorders, or clinical features suggestive of a chromosomal syndrome
 NA
 NA
 5451227
 2
 0
 2
 leppa_16_ASD_discovery_cases
 Children affected with ASD from 1,464 families from the Autism Genetic Resource Exchange (AGRE)
 1764
 Diagnosis according to ADOS and ADI-R
 N/A
 N/A
 1200000
 0
 1
 1
 maini_18_ASD/DD/ID_discovery_cases
  NA NA
 Patients evaluated at the Clinical Genetics Unit of Arcispedale Santa Maria Nuova, AUSL-IRCCS of Reggio Emilia that were investigated through aCGH between 2005 and 2016
 293
 Cases presented with one or more neurodevelopmental disorders (NDD), multiple congenital anomalies (MCA), and/or dysmorphic features. Most frequent neurodevelopmental diagnoses include language delay (78.5%), intellectual disability (66.4%), motor delay (50.7%), and ASD (13.9%); dysmorphic features were also frequently observed (52.7%)
 Mean age, 7 yrs. (range, 1 mo.-29 yrs.)
 57.5% Male
 5600000
 1
 0
 1
 oikonomakis_16_ASD_discovery_cases
 ASD cases evaluated with chromosomal microarray (CMA) from 2008-2015
 195
 Cases assessed for ASD according to DSM-IV behavioral criteria
 Range, 1-38 yrs.
 64.61% Male
 8700000
 1
 0
 1
 tzetis_12_DD/ID_discovery_cases
 Patients referred for aCGH analysis from 2008-present
 334
 Cases presented with at least one of the following clinical indications: developmental delay (DD), intellectual disability (ID), dysmorphic features, unique or multiple congenital anomalies (MCA), growth disorder, behavior disorder, and/or autism (ASD)
 Range, 1 month-38 years (median age of 4 years)
 
 8700000
 1
 0
 1
 yamamoto_14_DD/ID/EP_discovery_cases
 Patients with microdeletions involving the 15q22.2 region presenting with neurological symptoms
 4
 Developmental delay/intellectual disability (all 4 cases), epilepsy (3 cases), and autistic features (1 case)
 Range, 3-14 yrs.
 50% Male
 6500000
 3
 0
 1

Controls

Cohort ID
Author, Year
Descripton
Cohort Size
Diagnosis
Age
Gender
CNV Size
Deletion
Duplication
Total CNV's
 kaminsky_11_DD/ID/ASD_discovery_controls
 Controls from the International Standards for Cytogenomic Arrays (ISCA) consortium
 10118
 Controls
 NA
 NA
 NA
 NA
 NA
 NA
 leppa_16_ASD_discovery_controls
 Unaffected children from 1,464 families from the Autism Genetic Resource Exchange (AGRE)
 572
 Control
 N/A
 N/A
 1200000
 0
 2
 2

Cases

Cohort ID
Geographical Ancestry
Discovery Method
Platform
Algorithm
Software
Validation Method
 kaminsky_11_DD/ID/ASD_discovery_cases
  NA
 aCGH
  Agilent 44K, Agilent 105K
 
 Feature Extraction, DNA Analytics
 FISH, qPCR, MLPA, aCGH, standard G-banded chromosome analysis
 leppa_16_ASD_discovery_cases
  N/A
 Solid phase hybridization
  Illumina 550v1 and 550v3, Omni-1.0-B and -H, Omni 2.5
 PennCNV, QuantiSNP, GNOSIS
 GenomeStudio, CNVision
 None
 maini_18_ASD/DD/ID_discovery_cases
  Italian
 aCGH, array SNP
  Multiple platforms, including Agilent and Affymetrix arrays (8x60K oligochips since 2012)
 
 
 None
 oikonomakis_16_ASD_discovery_cases
  Greece
 aCGH
  Agilent 244K, 4x180K, or 4x180K (SurePrint G3 arrays)
 
 
 None
 tzetis_12_DD/ID_discovery_cases
  Greece
 aCGH
  Agilent 244K, Agilent 4x180K
 ADM-1
 Agilent Feature Extraction V9.1, Agilent CGH Analytics V4.0, Illumina GenomeStudio V2011.1
 None
 yamamoto_14_DD/ID/EP_discovery_cases
  N/A
 aCGH
  Agilent 60K, Agilent 44K
 
 
 FISH, microarray

Controls

Cohort ID
Geographical Ancestry
Discovery Method
Platform
Algorithm
Software
Validation Method
  kaminsky_11_DD/ID/ASD_discovery_controls
  NA
  aCGH
  Agilent 44K, Agilent 105K
 
  Feature Extraction, DNA Analytics
 
  leppa_16_ASD_discovery_controls
  N/A
  Solid phase hybridization
  Illumina 550v1 and 550v3, Omni-1.0-B and -H, Omni 2.5
  PennCNV, QuantiSNP, GNOSIS
  GenomeStudio, CNVision
  None

Cases

Patient ID
Author, Year
Age
Gender
Primary Diagnosis
Clinical Profile
Cognitive Profile
CNV Start
CNV End
CNV Size
Genome Build
Type Method
Validation
  kaminsky_11_DD/ID/ASD_discovery_cases-ISCA00000879
 NA
 NA
 Developmental delay/intellectual disability/ASD
 Clinical profile NA
 Cognitive profile NA
 57456076
 61907285
  4451210
 GRCh38
 Deletion
 Yes
  kaminsky_11_DD/ID/ASD_discovery_cases-ISCA00002325
 NA
 NA
 Developmental delay/intellectual disability/ASD
 Clinical profile NA
 Cognitive profile NA
 57567950
 63019415
  5451466
 GRCh38
 Deletion
 Yes
  leppa_16_ASD_discovery_cases-AU046706
 N/A
 M
 ASD
 
 
 58571801
 59776801
  1205001
 GRCh38
 Duplication
 No
  maini_18_ASD/DD/ID_discovery_cases-case_unknown41
  NA NA
 N/A
 N/A
 NDD/MCA/dysmorphic features
 CNV was identified in an individual with one or more neurodevelopmental disorders (NDD), multiple congenital anomalies (MCA), and/or dysmorphic features (detailed clinical information was not available). CNV classified as pathogenic
 
 55571688
 61185835
  5614148
 GRCh38
 Deletion
 No
  oikonomakis_16_ASD_discovery_cases-case258
 3 yrs.
 F
 ASD
 Case was assessed for ASD according to DSM-IV behavioral criteria. Clinical characteristics other than ASD: hypotonia, arched eyebrows, low set ears, microotia, macroglossia, open mouth, drooling
 
 53082409
 61810557
  8728149
 GRCh38
 Deletion
 No
  tzetis_12_DD/ID_discovery_cases-case39
 
 F
 DD/ID
 Small low set ears with hypoplastic ears, blepharophimosis, macroglossia, arched eyebrows, facial hypotonia with pen mouth appearance
 
 53082409
 61810557
  8728149
 GRCh38
 Deletion
 No
  yamamoto_14_ID/EP_discovery_cases-case1
 3 yrs.
 F
 Developmental delay
 Case present in DECIPHER database (DECIPHER ID #271644). Birth/neonatal history: delivered by C-section due to brecch presentation at 37 weeks and 5 days gestation; no complications during pregnancy; birth weight of 2712 g (50th-90th %ile) and OFC of 30.0 cm (<10th %ile). Developmental milestones: motor developmental delay from early infancy; head control at 4 months, rolling over at 12 months, sitting unsupported at 12 months, walking at 31 months; first meaningful word at 11 months of age. Language and communication evaluation: able to understand some simple oral suggestions and speak some meaningful words, but unable to speak more than two words. Behavioral/psychiatric evaluation: self-injurious behavior; often shows startle response when she suddenly hears a loud sound; no sleep disturbance. Brain imaging: cranial tomography showed no abnormalities. Dysmorphic features: frontal bossing, short palpebral fissures, hypertelorism, telecanthus, flat nasal bridge, anteverted nares, thin lips, open mouth, pointed chin, right simian crease, strabismus of left eye. Growth parameters: macrocephaly; height of 80.0 cm (-1.8 SD), weight of 12.3 kg (+0.3 SD), and OFC of 50.8 cm (+2.1 SD).
 Mild developmental delay; developmental quotient of 67
 55658902
 62192217
  6533316
 GRCh38
 Deletion
 Yes
  yamamoto_14_ID/EP_discovery_cases-case3
 13 yrs.
 F
 Intellectual disability and epilepsy
 Case present in DECIPHER database (DECIPHER ID #253216). Birth/neonatal history: born at 41 weeks of gestation; birth weight of 3210 g (50th-75th %ile), length of 50 cm (90th-97th %ile), and OFC of 34.4 cm (75th-90th %ile); unremarkable pregnancy and delivery. Developmental milestones: growth delay at age of 20 months (weight -2.0 SD, height -1.0 SD, OFC -2.0 SD). Language and communication evaluation: no reading or writing skills, poor language skills. Motor and musculoskeletal evaluation: dysmetria, apraxia, ataxia, intention tremor; thin and long fingers, slight clinodactyly of both index fingers. Epilpesy/seizures: experienced spasm associated with syncope and convulsive motion at 20 months of age; status epilepticus at age of 4 years despite prescription of anti-epileptic drugs; intractable complex partial epilepsy. EEG: sleep EEG showed abnormal activities in left hemisphere of brain. Brain imaging: brain MRI showed partial agenesis of the vermis. Dysmorphic features: square face, prominent forehead, short philtrum, up-slanting palpebral fissures, thin lips, pointed chin. Growth parameters: overweight; weight of 42 kg (+1.0 SD), length of 141.5 cm (-2.0 SD), and OFC of 53 cm (mean [M]).
 Severe intellectual disability (unable to accurately assess IQ)
 57550472
 63062011
  5511540
 GRCh38
 Deletion
 No
  yamamoto_14_ID/EP_discovery_cases-case4
 14 yrs.
 M
 Intellectual disability, epilepsy, and autistic features
 Case present in DECIPHER database (DECIPHER ID #270602). Birth/neonatal history: born at 41 weeks of gestation; birth weight of 3400 g (M), length of 52 cm (+2.0 SD), and OFC of 35 cm (M); unremarkable pregnancy. Developmental milestones: head control and following things with his eyes at 4 months; started to walk at age of 24 months; significant delay in language development. Language and communication evaluation: able to speak about 50 meaningful words at age of 11 years. Motor and musculoskeletal evaluation: short hands, pes cavus. Behavioral/psychiatric evaluation: autistic features; no reported sleep disturbances, no abnormal eating behavior. Epilepsy/seizures: patient started to show seizure attacks associated with drooling, which were intractable to antiepileptic treatment, at 3 months of age. Other features: ophthalmological surgery performed to correct strabismus at age of 9 years; puberty has not started in patient. Dysmorphic features: square face, prominent forehead, short philtrum, pointed chin, brachycephaly, downturned corners of mouth, deep-set eyes, prominent ears, strabismus (surgically corrected).
 Mild-moderate intellectual disability; estimated developmental quotient of 50
 58668900
 61223825
  2554926
 GRCh38
 Deletion
 Yes

Controls

Patient ID
Author, Year
Age
Gender
Primary Diagnosis
Clinical Profile
Cognitive Profile
CNV Start
CNV End
CNV Size
Genome Build
Type Method
Validation
  leppa_16_ASD_discovery_controls-AU046704
  N/A
  F
  Control
  Unaffected sibling
 
  58571801
  59776801
  1205001
  GRCh38
  Duplication
  No
  leppa_16_ASD_discovery_controls-AU046705
  N/A
  M
  Control
  Unaffected sibling
 
  58571801
  59776801
  1205001
  GRCh38
  Duplication
  No

Cases

Patient ID
Validation Description
Primary Disorder Inheritence
Inheritence
Family Profile
Disease Segregation
Gene Content
Altered Gene Expression
 kaminsky_11_DD/ID/ASD_discovery_cases-ISCA00000879
 FISH, qPCR, MLPA, aCGH, or standard G-banded chromosome analysis
 
 Unknown
 Unknown
 Unknown
 MTCO3P23,MTND3P12,MTND5P32,MTCYBP23,HMGB1P51,HSP90AB4P,ZNF444P1,MIR2116,LDHAL6B,RNU4-80P,RNU6-212P,RNA5SP396,PIGHP1,MESTP2,CYCSP38,RNA5SP397,LINC02349,POLR2M,AQP9,RN7SKP95,SLTM,GTF2A2,BNIP2,NMNAT1P5,ANXA2,CGNL1,ALDH1A2,LIPC,LIPC-AS1,MINDY2,RNF111,CCNB2,MYO1E,FAM81A,GCNT3,FOXB1,ICE2,RORA-AS1,RORA-AS2,GCOM1,MYZAP,RPS3AP6,RORA,VPS13C,ADAM10
 
 kaminsky_11_DD/ID/ASD_discovery_cases-ISCA00002325
 FISH, qPCR, MLPA, aCGH, or standard G-banded chromosome analysis
 
 Unknown
 Unknown
 Unknown
 MTCO3P23,MTND3P12,MTND5P32,MTCYBP23,HMGB1P51,HSP90AB4P,ZNF444P1,MIR2116,LDHAL6B,RNU4-80P,RNU6-212P,RNA5SP396,PIGHP1,MESTP2,CYCSP38,RNA5SP397,LINC02349,C2CD4A,NPM1P47,C2CD4B,MIR8067,MIR6085,HMGN1P26,MGC15885,MIR190A,POLR2M,AQP9,RN7SKP95,SLTM,GTF2A2,BNIP2,NMNAT1P5,ANXA2,ALDH1A2,LIPC,LIPC-AS1,MINDY2,RNF111,CCNB2,MYO1E,FAM81A,GCNT3,FOXB1,ICE2,RORA-AS1,RORA-AS2,GOLGA2P11,TLN2,GCOM1,MYZAP,RPS3AP6,RORA,VPS13C,ADAM10
 
 leppa_16_ASD_discovery_cases-AU046706
 
 
 Maternal
 Multiplex
 Not segregated (CNV not present in affected siblings but is present in unaffected siblings AU046704 and AU046705)
 HMGB1P51,HSP90AB4P,ZNF444P1,MIR2116,LDHAL6B,RNU4-80P,RNU6-212P,RNA5SP396,PIGHP1,RN7SKP95,SLTM,GTF2A2,BNIP2,MINDY2,RNF111,CCNB2,MYO1E,FAM81A,GCNT3,RPS3AP6,ADAM10
 
 maini_18_ASD/DD/ID_discovery_cases-case_unknown41
 
 
 De novo
 Unknown
 Unknown
 CNOT6LP1,RN7SL568P,CD24P2,RNU6-1287P,HMGB1P33,HNRNPA3P11,LINC00926,LINC01413,NDUFB10P1,RNU6-844P,MTCO3P23,MTND3P12,MTND5P32,MTCYBP23,HMGB1P51,HSP90AB4P,ZNF444P1,MIR2116,LDHAL6B,RNU4-80P,RNU6-212P,RNA5SP396,PIGHP1,MESTP2,CYCSP38,RNA5SP397,MNS1,ZNF280D,POLR2M,AQP9,RN7SKP95,SLTM,GTF2A2,BNIP2,NMNAT1P5,ANXA2,PRTG,NEDD4,RFX7,TEX9,TCF12,CGNL1,ALDH1A2,LIPC,LIPC-AS1,MINDY2,RNF111,CCNB2,MYO1E,FAM81A,GCNT3,FOXB1,ICE2,RORA-AS1,RORA-AS2,PYGO1,GCOM1,MYZAP,RPS3AP6,RORA,ADAM10
 
 oikonomakis_16_ASD_discovery_cases-case258
 
 
 Unknown
 
 
 RNU2-53P,RNU6-449P,HNRNPA1P74,PIGBOS1,MIR628,CNOT6LP1,RN7SL568P,CD24P2,RNU6-1287P,HMGB1P33,HNRNPA3P11,LINC00926,LINC01413,NDUFB10P1,RNU6-844P,MTCO3P23,MTND3P12,MTND5P32,MTCYBP23,HMGB1P51,HSP90AB4P,ZNF444P1,MIR2116,LDHAL6B,RNU4-80P,RNU6-212P,RNA5SP396,PIGHP1,MESTP2,CYCSP38,RNA5SP397,LINC02349,LINC02490,PIGB,CCPG1,C15orf65,MNS1,ZNF280D,POLR2M,AQP9,RN7SKP95,SLTM,GTF2A2,BNIP2,NMNAT1P5,ANXA2,WDR72,RSL24D1,RAB27A,DNAAF4-CCPG1,DNAAF4,PRTG,NEDD4,RFX7,TEX9,TCF12,CGNL1,ALDH1A2,LIPC,LIPC-AS1,MINDY2,RNF111,CCNB2,MYO1E,FAM81A,GCNT3,FOXB1,ICE2,RORA-AS1,RORA-AS2,UNC13C,PYGO1,GCOM1,MYZAP,RPS3AP6,RORA,ADAM10
 
 tzetis_12_DD/ID_discovery_cases-case39
 
 
 Unknown
 Unknown
 
 RNU2-53P,RNU6-449P,HNRNPA1P74,PIGBOS1,MIR628,CNOT6LP1,RN7SL568P,CD24P2,RNU6-1287P,HMGB1P33,HNRNPA3P11,LINC00926,LINC01413,NDUFB10P1,RNU6-844P,MTCO3P23,MTND3P12,MTND5P32,MTCYBP23,HMGB1P51,HSP90AB4P,ZNF444P1,MIR2116,LDHAL6B,RNU4-80P,RNU6-212P,RNA5SP396,PIGHP1,MESTP2,CYCSP38,RNA5SP397,LINC02349,LINC02490,PIGB,CCPG1,C15orf65,MNS1,ZNF280D,POLR2M,AQP9,RN7SKP95,SLTM,GTF2A2,BNIP2,NMNAT1P5,ANXA2,WDR72,RSL24D1,RAB27A,DNAAF4-CCPG1,DNAAF4,PRTG,NEDD4,RFX7,TEX9,TCF12,CGNL1,ALDH1A2,LIPC,LIPC-AS1,MINDY2,RNF111,CCNB2,MYO1E,FAM81A,GCNT3,FOXB1,ICE2,RORA-AS1,RORA-AS2,UNC13C,PYGO1,GCOM1,MYZAP,RPS3AP6,RORA,ADAM10
 
 yamamoto_14_ID/EP_discovery_cases-case1
 FISH
 
 De novo
 
 Likely segregated
 CNOT6LP1,RN7SL568P,CD24P2,RNU6-1287P,HMGB1P33,HNRNPA3P11,LINC00926,LINC01413,NDUFB10P1,RNU6-844P,MTCO3P23,MTND3P12,MTND5P32,MTCYBP23,HMGB1P51,HSP90AB4P,ZNF444P1,MIR2116,LDHAL6B,RNU4-80P,RNU6-212P,RNA5SP396,PIGHP1,MESTP2,CYCSP38,RNA5SP397,LINC02349,C2CD4A,NPM1P47,C2CD4B,MNS1,ZNF280D,POLR2M,AQP9,RN7SKP95,SLTM,GTF2A2,BNIP2,NMNAT1P5,ANXA2,PRTG,NEDD4,RFX7,TEX9,TCF12,CGNL1,ALDH1A2,LIPC,LIPC-AS1,MINDY2,RNF111,CCNB2,MYO1E,FAM81A,GCNT3,FOXB1,ICE2,RORA-AS1,RORA-AS2,GCOM1,MYZAP,RPS3AP6,RORA,VPS13C,ADAM10
 
 yamamoto_14_ID/EP_discovery_cases-case3
 
 
 Unknown
 
 Unknown
 MTCO3P23,MTND3P12,MTND5P32,MTCYBP23,HMGB1P51,HSP90AB4P,ZNF444P1,MIR2116,LDHAL6B,RNU4-80P,RNU6-212P,RNA5SP396,PIGHP1,MESTP2,CYCSP38,RNA5SP397,LINC02349,C2CD4A,NPM1P47,C2CD4B,MIR8067,MIR6085,HMGN1P26,MGC15885,MIR190A,TPM1-AS,POLR2M,AQP9,RN7SKP95,SLTM,GTF2A2,BNIP2,NMNAT1P5,ANXA2,CGNL1,ALDH1A2,LIPC,LIPC-AS1,MINDY2,RNF111,CCNB2,MYO1E,FAM81A,GCNT3,FOXB1,ICE2,RORA-AS1,RORA-AS2,GOLGA2P11,TLN2,TPM1,GCOM1,MYZAP,RPS3AP6,RORA,VPS13C,ADAM10
 
 yamamoto_14_ID/EP_discovery_cases-case4
 Microarray
 
 De novo
 
 Likely segregated
 HMGB1P51,HSP90AB4P,ZNF444P1,MIR2116,LDHAL6B,RNU4-80P,RNU6-212P,RNA5SP396,PIGHP1,MESTP2,CYCSP38,RNA5SP397,RN7SKP95,SLTM,GTF2A2,BNIP2,NMNAT1P5,ANXA2,MINDY2,RNF111,CCNB2,MYO1E,FAM81A,GCNT3,FOXB1,ICE2,RORA-AS1,RORA-AS2,RPS3AP6,RORA,ADAM10
 

Controls

Patient ID
Validation Description
Primary Disorder Inheritence
Inheritence
Family Profile
Disease Segregation
Gene Content
Altered Gene Expression
leppa_16_ASD_discovery_controls-AU046704
 
 
  Maternal
  Multiplex
 
  HMGB1P51,HSP90AB4P,ZNF444P1,MIR2116,LDHAL6B,RNU4-80P,RNU6-212P,RNA5SP396,PIGHP1,RN7SKP95,SLTM,GTF2A2,BNIP2,MINDY2,RNF111,CCNB2,MYO1E,FAM81A,GCNT3,RPS3AP6,ADAM10
 
leppa_16_ASD_discovery_controls-AU046705
 
 
  Maternal
  Multiplex
 
  HMGB1P51,HSP90AB4P,ZNF444P1,MIR2116,LDHAL6B,RNU4-80P,RNU6-212P,RNA5SP396,PIGHP1,RN7SKP95,SLTM,GTF2A2,BNIP2,MINDY2,RNF111,CCNB2,MYO1E,FAM81A,GCNT3,RPS3AP6,ADAM10
 

No Animal Model Data Available
HELP
Copyright © 2017 MindSpec, Inc.